Vanda Pharmaceuticals, Inc. (VNDA)
6.85
-0.15
(-2.14%)
USD |
NASDAQ |
Apr 06, 13:21
Vanda Pharmaceuticals Total Liabilities (Quarterly) : 161.76M for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Gilead Sciences, Inc. | 36.40B |
| Eli Lilly & Co. | 85.94B |
| Gossamer Bio, Inc. | 295.01M |
| Arcellx, Inc. | 201.64M |
| AnaptysBio, Inc. | 327.18M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 488.95M |
| Shareholders Equity (Quarterly) | 327.19M |
| Debt to Equity Ratio | 0.0386 |
| Current Ratio | 2.392 |
| Net Debt Paydown Yield | -0.18% |